Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects

European Journal of Nuclear Medicine

Volumn 29, Issue 12, 2002, Pages 1600-1607

  Kofoed, Klaus F ^a   Hove, Jens D ^a   Freiberg, Jacob ^a   Høst, Ulla ^a   Holm, Søren ^a   Kelbæk, Henning ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

13N Ammonia; 18F Fluorodeoxyglucose; Glucose; Myocardium; Positron emission tomography

Indexed keywords

AMMONIUM DERIVATIVE; DIPYRIDAMOLE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; NITROGEN 13; AMMONIA; DIAGNOSTIC AGENT; NITROGEN; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BICYCLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; HYPERINSULINEMIA; INSULIN SENSITIVITY; LINEAR REGRESSION ANALYSIS; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; REST; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE; HYPERINSULINISM; METABOLISM; METHODOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; BICYCLE ERGOMETRY; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE;

AMMONIA; BLOOD GLUCOSE; DIPYRIDAMOLE; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEART VENTRICLES; HUMANS; HYPEREMIA; HYPERINSULINISM; INSULIN; MALE; MIDDLE AGED; NITROGEN RADIOISOTOPES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; VENTRICULAR FUNCTION, LEFT;

EID: 0036451965     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0972-5     Document Type: Article

References (38)

1. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982; 23:577-586.
2. Ng CK, Soufer R, McNulty PH. Effect of hyperinsulinemia on myocardial fluorine-18-F-FDG uptake. J Nucl Med 1998; 39:379-383.
3. 18F]2-fluorodeoxyglucose and PET. Cardiovasc Res 2000; 45:321-329.
4. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation 1993; 87:1513-1523.
5. Marinho NV, Keogh BE, Costa DC, Lammertsma AA, Ell PJ, Camici PG. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 1996; 93:737-744.
6. Maki M, Luotolahti M, Nuutila P, Iida H, Voipio-Pulkki LM, Ruotsalainen U, Haaparanta M, Solin O, Hartiala J, Harkonen R, Knuuti J. Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation 1996; 93:1658-1666.
7. Kofoed KF, Carstensen S, Hove JD, Freiberg J, Bangsgaard R, Holm S, Rabøl A, Hesse B, Arendrup H, Kelbæk H. Low whole-body insulin sensitivity in patients with ischemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularization. Eur J Nucl Med Mol Imaging 2002; 2:991-998.
8. Knuuti MJ, Nuutila P, Ruotsalainen U, et al. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med 1993; 34:2068-2075.
9. Gerber BL, Ordoubadi FF, Wijns W, Vanoverschelde JL, Knuuti MJ, Janier M, Melon P, Blanksma PK, Bol A, Bax JJ, Melin JA, Camici PG. Positron emission tomography using (18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: Optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of (18)F-fluoro-deoxyglucose positron emission tomography for the detection of myocardial viability. Eur Heart J 2001; 22:1691-1701.
10. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999; 99:578-588.
11. De Fronzo RA, Jordan DT, Reubin A. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237:E214-E223.
12. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3:1-7.
13. Hicks RJ, Herman WH, Kalff V, Molina E, Wolfe ER, Hutchins G, Schwaiger M. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol 1991; 18:101-111.
14. Knuuti MJ, Nuutila P, Ruotsalainen U, et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 1992; 33:1255-1262.
15. Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001; 50:151-161.
16. Baron AD, Tarshoby M, Hook G, Lazaridis EN, Cronin J, Johnson A, Steinberg HO. Interaction between insulin sensitivity and muscle perfusion on glucose uptake in human skeletal muscle: Evidence for capillary recruitment. Diabetes 2000; 49:768-774.
17. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001; 50:241-247.
18. Kofoed KF, Czernin J, Johnson J, Kobashigawa J, Phelps ME, Laks H, Schelbert HR. Effects of cardiac allograft vasculopathy on myocardial blood flow, vasodilatory capacity, and coronary vasomotion. Circulation 1997; 95:600-606.
19. Nyboe J, Jensen G, Appleyard M, Schnohr P. Risk factors for acute myocardial infarction in Copenhagen. I: Hereditary, educational and socioeconomic factors. Copenhagen City Heart Study. Eur Heart J 1989; 10:910-916.
20. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary- artery disease. N Engl J Med 1979; 300:1350-1358.
21. Paternostro G, Camici PG, Lammerstma AA, Marinho N, Baliga RR, Kooner JS, Radda GK, Ferrannini E. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 1996; 98:2094-2099.
22. McFalls EO, Baldwin D, Marx D, Fashingbauer P, Ward HB. Effect of regional hyperemia on myocardial uptake of 2-deoxy-2-[(18)F]fluoro-D-glucose. Am J Physiol Endocrinol Metab 2000; 278:E96-E102.
23. 13N ammonia uptake in normal myocardium assessed by positron emission tomography. Patterns of mismatch and effects of aging. Int J Card Imaging 2001; 17:361-370.
24. Freiberg J, Hove JD, Fritz-Hansen T, Kofoed KF, Holm S, Høst U, Meyer C, Hesse B, Larsson H, Paulson O, Kelbæk H. Quantitation of cardiac volumes using gated positron emission tomography [abstract]. J Nucl Cardiol 1999; 6 (1):S11.
25. Gerber BL, Vanoverschelde JL, Bol A, Michel C, Labar D, Wijns W, Melin JA. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. Circulation 1996; 94:651-659.
26. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Aoyagi T, Sugiura S, Yamada N, Ohtomo K, Sasaki Y, Omata M, Yazaki Y. Insulin action on heart and skeletal muscle F-FDG uptake in patients with hypertriglyceridemia. J Nucl Med 1999; 40:1116-1121.
27. 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 1992; 86:1004-1017.
28. Peltoniemi P, Yki-Jarvinen H, Laine H, Oikonen V, Ronnemaa T, Kalliokoski K, Raitakari O, Knuuti MJ, Nuutila P. Evidence for spatial heterogeneity in insulin- and exercise-induced increases in glucose uptake: Studies in normal subjects and patients with type 1 diabetes. J Clin Endocrinol Metab 2001; 86:5525-5533.
29. Gropler RJ, Siegel BA, Lee KJ, Moerlein SM, Perry DJ, Bergmann SR, Geltman EM. Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med 1990; 31:1749-1756.
30. Choi Y, Brunken RC, Hawkins RA, Huang SC, Buxton DB, Hoh CK, Phelps ME, Schelbert HR. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993; 20:308-318.
31. Fallavollita JA. Spatial heterogeneity in fasting and insulin-stimulated (18)F-2-deoxyglucose uptake in pigs with hibernating myocardium. Circulation 2000; 102:908-914.
32. Ferrannini E, Santore D. Metabolic and hemodynamic effects of insulin on humans. Am J Physiol 1993; 264:E308-E315.
33. Nuutila P, Koivisto VA, Knuuti J, et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992; 89:1767-1774.
34. Balcells E, Suarez J, Rubio R. Implications of the coronary vascular endothelium as mediator of the vasodilatory and dromotropic actions of adenosine. J Mol Cell Cardiol 1993; 25:693-706.
35. Buus NH, Bottcher M, Hermansen F, Sander M, Nielsen TT, Mulvany MJ. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 2001; 104:2305-2310.
36. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary- artery disease. N Engl J Med 1979; 300:1350-1358.
37. Hariharan R, Bray M, Ganim R, Doenst T, Goodwin GW, Taegtmeyer H. Fundamental limitations of [(18)F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake. Circulation 1995; 91:2435-2444.
38. 18F]fluorodeoxyglucose. J Nucl Cardiol 1997; 4:125-132.